Neuroendocrine Tumors: Treatment and Management.
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Aug 2022
22 Aug 2022
Historique:
received:
05
08
2022
revised:
16
08
2022
accepted:
18
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
This Topical Collection consists of a series of articles presented by a panel of internationally recognized experts and compiles several clinical accomplishments in the field of neuroendocrine tumors (NETs) [...].
Identifiants
pubmed: 36011040
pii: cancers14164048
doi: 10.3390/cancers14164048
pmc: PMC9406630
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Cancers (Basel). 2021 Apr 07;13(8):
pubmed: 33916960
Cancers (Basel). 2021 Dec 19;13(24):
pubmed: 34944988
Cancers (Basel). 2021 Nov 27;13(23):
pubmed: 34885079
Cancers (Basel). 2021 May 18;13(10):
pubmed: 34070035
Cancers (Basel). 2021 Oct 15;13(20):
pubmed: 34680321
Cancers (Basel). 2021 Feb 05;13(4):
pubmed: 33562643
Cancers (Basel). 2021 Jul 27;13(15):
pubmed: 34359666
Cancers (Basel). 2021 Dec 15;13(24):
pubmed: 34944910
Cancers (Basel). 2021 Apr 10;13(8):
pubmed: 33920195
Cancers (Basel). 2021 Dec 30;14(1):
pubmed: 35008341
Cancers (Basel). 2021 Oct 30;13(21):
pubmed: 34771639
Cancers (Basel). 2021 Nov 26;13(23):
pubmed: 34885063
Cancers (Basel). 2022 Feb 22;14(5):
pubmed: 35267427
Cancers (Basel). 2022 Jan 30;14(3):
pubmed: 35158996
Cancers (Basel). 2021 Dec 28;14(1):
pubmed: 35008293